Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat


Tytuł :
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
Autorzy :
Fan L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fei X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhu Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pan J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sha J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chi C; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gong Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Du X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhou L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Dong B; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xue W; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 461-469. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sequence Analysis, DNA*
Circulating Tumor DNA/*blood
Circulating Tumor DNA/*genetics
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*genetics
Aged ; Androgen Antagonists/therapeutic use ; Genomics ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Autorzy :
Xu MC; Vanderbilt University School of Medicine, Nashville, Tennessee.
Huelster HL; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Hatcher JB; Vanderbilt University School of Medicine, Nashville, Tennessee.
Avulova S; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Stocks BT; Vanderbilt University School of Medicine, Nashville, Tennessee.
Glaser ZA; Vanderbilt University School of Medicine, Nashville, Tennessee.
Moses KA; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Silver HJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 800-805. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Obesity/*complications
Prostatic Neoplasms/*pathology
Sarcopenia/*complications
Adipose Tissue/diagnostic imaging ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Muscle, Skeletal/diagnostic imaging ; Neoplasm Metastasis ; Neoplasm Staging ; Obesity/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Sarcopenia/diagnostic imaging ; Survival Rate ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.
Autorzy :
Shore N; Carolina Urologic Research Center , Myrtle Beach, South Carolina.
Oliver L; Adelphi Values PROVE , Manchester, UK.
Shui I; Merck & Co.Inc., Kenilworth, New Jersey.
Gayle A; AstraZeneca , Cambridge, UK.
Wong OY; Adelphi Values PROVE , Manchester, UK.
Kim J; Merck & Co.Inc., Kenilworth, New Jersey.
Payne S; AstraZeneca , Cambridge, UK.
Amin S; AstraZeneca , Cambridge, UK.
Ghate S; Merck & Co.Inc., Kenilworth, New Jersey.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 977-986. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Recombinational DNA Repair*
Biomarkers, Tumor/*genetics
Prostatic Neoplasms, Castration-Resistant/*epidemiology
Prostatic Neoplasms, Castration-Resistant/*genetics
Circulating Tumor DNA/genetics ; DNA Mutational Analysis ; Disease Progression ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Male ; Neoplasm Metastasis ; Prevalence ; Prognosis ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/pathology
Czasopismo naukowe
Tytuł :
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?
Autorzy :
Stonier T; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.; St George's Hospital, London, UK.
Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Jibara G; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Fine S; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Eastham J; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1063-1068. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Patient Selection*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*surgery
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Grading ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk Factors ; Watchful Waiting
Czasopismo naukowe
Tytuł :
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
Autorzy :
Wibmer AG; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Chaim J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lakhman Y; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lefkowitz RA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nincevic J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nikolovski I; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sala E; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Carlsson SV; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, Sahlgrenska Academy at University of Gothenburg, Institute of Clinical Sciences, Gothenburg, Sweden.
Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Scardino P; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Hricak H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1055-1062. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Prostatectomy ; Prostatic Neoplasms/mortality ; Radiotherapy ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Patient Reported vs Claims Based Measures of Health for Modeling Life Expectancy in Men with Prostate Cancer. Reply.
Autorzy :
Tan HJ; Department of Urology, University of North Carolina, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1236-1237. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Life Expectancy*
Prostatic Neoplasms*/epidemiology
Age Factors ; Humans ; Male ; Patient Reported Outcome Measures
Czasopismo naukowe
Tytuł :
Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. Reply.
Autorzy :
Naha U; University of Illinois at Chicago, Chicago, Illinois.
Moreira DM; University of Illinois at Chicago, Chicago, Illinois.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1234-1235. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*
Prostatitis*/complications
Biopsy ; Humans ; Inflammation ; Male
Opinia redakcyjna
Tytuł :
Patient Reported vs Claims Based Measures of Health for Modeling Life Expectancy in Men with Prostate Cancer. Letter.
Autorzy :
Froehner M; Department of Urology, Zeisigwaldkliniken Bethanien Chemnitz, Chemnitz, Germany.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1235-1236. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Letter; Comment
MeSH Terms :
Life Expectancy*
Prostatic Neoplasms*/epidemiology
Age Factors ; Humans ; Male ; Patient Reported Outcome Measures
Opinia redakcyjna
Tytuł :
Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. Letter.
Autorzy :
Stavrinides V; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.; The Alan Turing Institute, London, UK.
Freeman A; Department of Pathology, University College London Hospital NHS Foundation Trust, London, UK.
Ball R; Department of Pathology, University College London Hospital NHS Foundation Trust, London, UK.
Haider A; Department of Pathology, University College London Hospital NHS Foundation Trust, London, UK.
Pashayan N; Department of Applied Health Research, Institute of Epidemiology & Health, University College London, London, UK.
Moore CM; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Emberton M; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1233-1234. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*
Prostatitis*/complications
Biopsy ; Humans ; Inflammation ; Male
Opinia redakcyjna
Tytuł :
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
Autorzy :
Tosoian JJ; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Trock BJ; Johns Hopkins Brady Urological Institute, Baltimore, Maryland.
Morgan TM; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Salami SS; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Tomlins SA; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Spratt DE; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Siddiqui J; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Kunju LP; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan, Ann Arbor, Michigan.
Botbyl R; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Chopra Z; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Pandian B; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Eyrich NW; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Longton G; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Zheng Y; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Palapattu GS; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Wei JT; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Dow Division of Health Services Research, University of Michigan, Ann Arbor, Michigan.
Niknafs YS; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Chinnaiyan AM; Department of Urology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan, Ann Arbor, Michigan.; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 732-739. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Validation Study
MeSH Terms :
Antigens, Neoplasm/*urine
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*urine
Serine Endopeptidases/*urine
Aged ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/urine ; Biopsy ; Digital Rectal Examination ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Predictive Value of Tests ; Prospective Studies ; Prostatic Neoplasms/pathology ; Referral and Consultation/statistics & numerical data ; Risk Assessment/methods ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Does Baseline Serum Testosterone Influence Androgen Deprivation Therapy Outcomes in Hormone Naïve Patients with Advanced Prostate Cancer?
Autorzy :
Patel A; European School of Urology and EAU Research Foundation Clinical Studies Committee, London, UK.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 806-811. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Androgen Antagonists/*therapeutic use
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*drug therapy
Testosterone/*blood
Aged ; Biomarkers, Tumor/blood ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prognosis ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Survival Rate
Czasopismo naukowe
Tytuł :
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy.
Autorzy :
Kohaar I; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.; Henry Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland.
Chen Y; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Banerjee S; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Borbiev T; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.; Henry Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland.
Kuo HC; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.; Henry Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland.
Ali A; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Ravindranath L; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Kagan J; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
Srivastava S; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
Dobi A; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.; Henry Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland.
Sesterhenn IA; Joint Pathology Center, Silver Spring, Maryland.
Rosner IL; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Cullen J; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Srivastava S; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Petrovics G; Center for Prostate Disease Research, John P. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.; Henry Jackson Foundation for the Advancement of Military Medicine (HJF), Bethesda, Maryland.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 420-425. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Exosomes/*genetics
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Cohort Studies ; Diagnosis, Differential ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/urine
Czasopismo naukowe
Tytuł :
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.
Autorzy :
Crocerossa F; Division of Urology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Marchioni M; Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Urology Unit, SS Annunziata Hospital, Chieti, Italy.; Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Chieti, Italy.
Novara G; Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Carbonara U; Division of Urology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.; Department of Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy.
Ferro M; Department of Urology, European Institute of Oncology, Milan, Italy.
Russo GI; Department of Urology, University of Catania, Catania, Italy.
Porpiglia F; Division of Urology, Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.
Di Nicola M; Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Chieti, Italy.
Damiano R; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Autorino R; Division of Urology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.
Cantiello F; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 356-369. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Antigens, Surface*
Glutamate Carboxypeptidase II*
Neoplasm Recurrence, Local/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Prostatic Neoplasms/*diagnostic imaging
Humans ; Male ; Molecular Imaging ; Neoplasm Recurrence, Local/blood ; Network Meta-Analysis ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/surgery ; Radioactive Tracers
Czasopismo naukowe
Tytuł :
Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
Autorzy :
Pooli A; UCLA Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Johnson DC; UCLA Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Shirk J; UCLA Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Markovic D; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Sadun TY; UCLA Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Sisk AE Jr; Genitourinary Pathology, Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Mohammadian Bajgiran A; Diagnostic and Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Afshari Mirak S; Diagnostic and Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Felker ER; Diagnostic and Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Hughes AK; UCLA Health.
Raman SS; Diagnostic and Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Reiter RE; UCLA Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 444-451. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Preoperative Period ; Prostatectomy ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Tumor Burden
Czasopismo naukowe
Tytuł :
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
Autorzy :
Chu CE; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Cowan JE; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Fasulo V; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Washington SL 3rd; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
de la Calle C; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Shoemaker J; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Carroll PR; Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California (CEC, JEC, SLW, CdlC, JS, PRC), and Department of Urology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy (VF).
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Jan; Vol. 205 (1), pp. 109-114. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms/*diagnosis
Watchful Waiting/*methods
Aged ; Androgen Antagonists/therapeutic use ; Disease Progression ; Humans ; Image-Guided Biopsy/statistics & numerical data ; Kallikreins/blood ; Kaplan-Meier Estimate ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatectomy/statistics & numerical data ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/therapy ; Radiotherapy/statistics & numerical data ; Risk Assessment/statistics & numerical data ; Risk Factors ; Watchful Waiting/statistics & numerical data
Czasopismo naukowe
Tytuł :
Active Surveillance for Men with Intermediate Risk Prostate Cancer.
Autorzy :
Agrawal V; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York.
Ma X; Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Hu JC; Department of Urology, Weill Cornell Medicine, New York, New York.
Barbieri CE; Department of Urology, Weill Cornell Medicine, New York, New York.
Nagar H; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Jan; Vol. 205 (1), pp. 115-121. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article
MeSH Terms :
Health Status Disparities*
Healthcare Disparities/*statistics & numerical data
Prostatic Neoplasms/*therapy
Watchful Waiting/*statistics & numerical data
Age Factors ; Aged ; Aged, 80 and over ; Healthcare Disparities/economics ; Humans ; Insurance Coverage/economics ; Insurance Coverage/statistics & numerical data ; Insurance, Health/economics ; Insurance, Health/statistics & numerical data ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatectomy/economics ; Prostatectomy/statistics & numerical data ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Radiotherapy/economics ; Radiotherapy/statistics & numerical data ; Retrospective Studies ; Risk Factors ; Socioeconomic Factors ; Watchful Waiting/economics
Czasopismo naukowe
Tytuł :
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.
Autorzy :
Gregg JR; University of Texas MD Anderson Cancer Center, Houston, Texas.
Surasi DS; University of Texas MD Anderson Cancer Center, Houston, Texas.
Childs A; University of Texas MD Anderson Cancer Center, Houston, Texas.
Moll N; University of Texas MD Anderson Cancer Center, Houston, Texas.
Ward JF; University of Texas MD Anderson Cancer Center, Houston, Texas.
Kim J; Merck & Co., Inc., Kenilworth, New Jersey.
Daniel CR; University of Texas MD Anderson Cancer Center, Houston, Texas.
Logothetis C; University of Texas MD Anderson Cancer Center, Houston, Texas.
Bathala T; University of Texas MD Anderson Cancer Center, Houston, Texas.
Davis JW; University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Jan; Vol. 205 (1), pp. 122-128. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Adiposity/*physiology
Intra-Abdominal Fat/*physiopathology
Prostate/*pathology
Prostatic Neoplasms/*mortality
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy/statistics & numerical data ; Disease Progression ; Follow-Up Studies ; Humans ; Intra-Abdominal Fat/diagnostic imaging ; Kallikreins/blood ; Magnetic Resonance Imaging/statistics & numerical data ; Male ; Middle Aged ; Neoplasm Grading ; Organ Size ; Progression-Free Survival ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Subcutaneous Fat/diagnostic imaging ; Subcutaneous Fat/physiopathology
Czasopismo naukowe
Tytuł :
Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
Autorzy :
Borges RC; Department of Urology, Institut Mutualiste Montsouris, Paris, France.; Department of Urology, Faculdade de Medicina do ABC, São Paulo, Brazil.
Tourinho-Barbosa RR; Department of Urology, Institut Mutualiste Montsouris, Paris, France.; Department of Urology, Hospital Cardiopulmonar, Salvador, Brazil.
Glina S; Department of Urology, Faculdade de Medicina do ABC, São Paulo, Brazil.
Macek P; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
Mombet A; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
Sanchez-Salas R; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
Cathelineau X; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Jan; Vol. 205 (1), pp. 129-136. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Ablation Techniques/*adverse effects
Cryosurgery/*adverse effects
Erectile Dysfunction/*diagnosis
High-Intensity Focused Ultrasound Ablation/*adverse effects
Postoperative Complications/*diagnosis
Prostatic Neoplasms/*surgery
Urinary Incontinence/*diagnosis
Ablation Techniques/methods ; Aged ; Cryosurgery/methods ; Erectile Dysfunction/epidemiology ; Erectile Dysfunction/etiology ; Erectile Dysfunction/prevention & control ; Follow-Up Studies ; High-Intensity Focused Ultrasound Ablation/methods ; Humans ; Male ; Middle Aged ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Prostate/pathology ; Prostate/surgery ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Severity of Illness Index ; Treatment Outcome ; Urinary Incontinence/epidemiology ; Urinary Incontinence/etiology ; Urinary Incontinence/prevention & control
Czasopismo naukowe
Tytuł :
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer.
Autorzy :
Klotz L; Sunnybrook Health Sciences Centre , University of Toronto.
Pavlovich CP; Johns Hopkins.
Chin J; University of Western Ontario.
Hatiboglu G; University Hospital Heidelberg, German Cancer Research Center.
Koch M; Indiana University.
Penson D; Vanderbilt University Medical Center.
Raman S; UCLA Health Sciences.
Oto A; University of Chicago.
Fütterer J; Radboud University Medical Center.
Serrallach M; ResoFus Alomar (Hospital Universitari De Bellvitge).
Relle J; Beaumont Health System.
Lotan Y; UT Southwestern Medical Center.
Heidenreich A; University Hospital Cologne.
Bonekamp D; University Hospital Heidelberg, German Cancer Research Center.
Haider M; Joint Dept of Medical Imaging, Sinai Health System, Sunnybrook Research Institute, Lunenfeld Tanenbaum Research Institute and University of Toronto, Toronto, Canada.
Tirkes T; Indiana University.
Arora S; Vanderbilt University Medical Center.
Macura KJ; Johns Hopkins University.
Costa DN; UT Southwestern Medical Center.
Persigehl T
Pantuck AJ; UCLA Health Sciences.
Bomers J; Radboud University Medical Center.
Burtnyk M; Profound Medical.
Staruch R; Profound Medical.
Eggener S; University of Chicago.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 769-779. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
High-Intensity Focused Ultrasound Ablation*
Magnetic Resonance Imaging, Interventional*/methods
Prostatic Neoplasms/*surgery
Aged ; Aged, 80 and over ; Canada ; Europe ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Postoperative Complications ; Prospective Studies ; Prostatic Neoplasms/pathology ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies